Regenerative medicine symposium hosted by ISSCA in Buenos Aires, Argentina Aug. 24, 2018, exceeds expectations organizers report
Organizers of the ISSCA regenerative medicine symposium “Applications of Cell Therapies in Medicine and Aesthetic Surgery” held in Buenos Aires, Argentina Aug. 24, 2018, featured 16 physicians traveling from six countries— Mexico, Chile, Colombia, Spain, Costa RIca and the U.S. —to serve as guest speakers.
MIAMI, Aug. 30, 2018—Enthused by the extraordinary success of the International Association for Stem Cell Applications (ISSCA)’s regenerative medicine symposium held at Universidad de Buenos Aires in Argentina Aug. 24, 2018, ISSCA organizers have already begun discussing plans to host the next conference in Miami in summer, 2019.
The 5th annual “Applications of Cell Therapies in Medicine and Aesthetic Surgery,” hosted 250 attendees and featured more than 16 speakers from six countries to discuss the latest clinical stem cell applications for a variety of therapies and treatments including traumatic injuries, pain management, neurological conditions, sports injuries, heart failure, erectile effusion, and aesthetic medicine procedures.
The symposium provided attendees with an opportunity to learn about the most important clinical applications of stem cell therapies from experienced regenerative medicine practitioners.
Leonardo Tacus, M.D., an arthroscopic surgeon specializing in orthopedics, traumatology, and regenerative medicine, spoke to attendees about clinical applications of regenerative medicine therapies to treat injuries sustained by professional athletes.
Jose Benitez, Medical Director of Boston Médical Group Spain. who specializes in male sexual dysfunctions. spoke about stem cell applications used to treat erectile dysfunction.
Calling the symposium their most successful regenerative medicine event to date, iSSCA members and conference speakers held an informative Q&A session lasting three hours until all questions were answered. The session covered a variety of compelling topics regarding stem cell therapies. A lecture based on the symposium will soon be available on ISSCA’s YouTube channel.
Information on the summer, 2019 symposium will be made available in upcoming weeks. For more information, visit stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
regenerative medicine symposium Buenos Aires
- Published in Press Releases
ISSCA to sponsor International Congress on Advanced Therapies in Medicine in Riviera Nayarit, Mexico Nov. 24-25, 2018
ISSCA will sponsor the 6th annual International Congress on Advanced Therapies in Medicine Nov. 24-25, 2018 in Riviera Nayarit.
MIAMI, July 27, 2018—For the third consecutive year the International Association for Stem Cell Application (ISSCA) will sponsor the International Congress on Advanced Therapies in Medicine 2018 on Puerto Vallarta, Mexico.
The event will feature a commercial expo with 20 with 20 booths exhibiting new products and information for physicians in the field of regenerative medicine. More than 250 physicians are expected to be in attendance.
ISSCA will present information on its Fellowship in Cell Therapy and Tissue Engineering program, a 6-day course during which a group of experienced academicians involved in stem cell transplantation present the general principles and practice of stem cell biology and evidence-based treatments to physicians looking to optimize the treatment options that benefit the health of their patients. The fellowship program will be held in Korea Oct. 22-27, 2018.
Fellowship participants will take part in a detailed program offering hands-on experience in stem cell applications and learn cell culture protocols including plating, trypsinization, harvesting, and cryopreservation, as well as an understanding and application of quality control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma and sterility.
In addition, physicians participating in the ISSCA fellowship program will learn how to perform cGMP functions including cleanroom maintenance, gowning and environmental monitoring, while gaining insight on relevant applications of stem cell processing and regulations in a certified facility. ISSCA provides fellowship attendees with the tools necessary to implement regulatory and clinical guidelines when setting up a GMP facility, as well as copies of presentations, procedural protocols and all forms associated with a GMP facility provided.
Participating physicians learn to perform clinical procedures including lipoaspirate and bone marrow isolation, and reintroducing stem cells for various indications. Case books and full protocols for approximately 30 indications are also provided.
In addition, Global Stem Cells Group )GSCG) will present its stem cell processing center, a complete solution for providers to equip their practice facilities with an on-site regenerative medicine lab. Used for tissue processing, isolation, culturing and cryopreservation of stem cells, the stem cell processing center is designed to execute a state-of-the-art stem cell laboratory using the latest technology.
GSCG provides participating regenerative medicine teams with specialized training to implement high-level processes and therapies using the stem cell processing center for better clinical interpretation, better results while maintaining compliance with safety regulations and international standards.
GSCG’s stem cell laboratory solution represents a tremendous competitive advantage and differentiator that arms regenerative medicine practitioners with the ability to perform highly advanced stem cell procedures in their facilities.
The 2018 International Congress on Advanced Therapies in Medicine in Riviera Nayarit, Mexico will be held at the Hotel Krystal Grand in Nuevo Puerto Vallarta,
For more information and to register, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine.
ISSCA serves its members through advancements made in the specialty of regenerative medicine.ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven
major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stopepicenter for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
advanced therapies international congress
- Published in Press Releases
ISSCA to sponsor First Congress of Aesthetic Medicine in Asuncion, Paraguay Sept. 20-22, 2018
ISSCA will sponsor the First Congress of Aesthetic Medicine in Paraguay. Featured topics include stem cell applications and digital marketing strategies in aesthetic practices.
MIAMI, July 27, 2018—The International Society for Stem Cell Application (ISSCA) will sponsor the First Congress of Aesthetic Medicine in Asuncion, Paraguay Sept. 20-22, 2018.
The 3-day event will include the latest applications for stem cell therapies in aesthetic medicine.
Dra Silvina Pastrana, medical director of ISSCA affiliate Global Stem Cells Group’s (GSCG) Stem Cell Center in Buenos Aires, Argentina, will be the featured speaker.
Pastrana will discuss the role of stem cell applications in iatrogenic scar healing and share a clinical case involving stem cell therapies used to treat an iatrogenic scar patient.
Benito Novas, a global entrepreneur and medical marketing strategist in the fields of biotechnology, life sciences, and healthcare development, will speak to conference attendees about critical marketing strategies for recruiting aesthetic patients in the digital era.
Novas, Global Stem Cells Group CEO and ISSCA Director of Public Relations, will share digital marketing tactics designed to help aesthetic practices engage new patients.
Novas will discuss the latest tools for managing an aesthetic practice marketing campaign that incorporates social media, content marketing, influencer marketing and other strategies for successfully promoting physician practices.
“Consumers spend no less than three hours per day on social media, which makes it a valuable tool for attracting patients,” Novas says. “Physicians and medical practice administrators attending the conference will learn strategies for leveraging the power of online resources like Twitter, Facebook, and Instagram to reach target audiences, boost leads and effectively recruit new patients.”
Content marketing and other strategies presented at the conference will help aesthetic practices maximize opportunities to attract potential patients by enhancing online visibility while increasing engagement with target audiences.
The First Conference of Aesthetic Medicine in Paraguay will offer a host of regenerative medicine product information and educational activities for aesthetic practitioners.
The event will be held at the Hotel Excelsior in Asuncion, Paraguay To learn more and to register for the conference, visit the First Congress of Aesthetic Medicine website, visit the ISSCA website, email info@stemcellsgroup.com or call 305-560-5337.
About ISSA:|
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Paraguay aesthetic medicine congress
- Published in Press Releases
ISSCA announces fellowship in cell therapy and tissue engineering
As part of its ongoing efforts to meet growing demand among physicians for continuing education opportunities in advanced cell therapies and tissue banking, the International Society for Stem Cell Application (ISSCA) will hold its next Cell Therapy and Tissue Engineering Fellowship program in Seoul, Korea October 22 – 27, 2018.
ISSCA’s fellowship training program offers physicians an opportunity to build knowledge and increase their therapeutic skills by learning to employ new developments in tissue banking practices and advanced cellular therapies to utilize in their practices.
The fellowship training will enable participating physicians to improve their core skills and competencies in regenerative medicine, establish optimal protocols, policies, and practices in tissue, cell, and advanced therapies, and ultimately enable them to deliver superior services to their patients.
Participating physicians will have the advantage of active engagement with world-class cellular and tissue banking experts in an immersive, hands-on experience while learning theoretical and analytic methods. Fellowship mentors are seasoned professionals devoted to creating new medical technologies and laboratory applications in one of the most rapidly-growing areas of biomedical engineering.
Cell therapy and tissue engineering offer tremendous potential for a career as a practitioner or researcher. Today’s students can be tomorrow’s pioneers in improving the efficacy of medical treatments and advancing the healthcare industry.
Engineering human tissues and organs can provide new treatments and cures for diseases, including blood vessels, bone, cartilage, liver, pancreas, peripheral nerves, and skin cells. Cell therapies and tissue engineering have the potential to revolutionize disease remediation and tissue repair in miraculous ways.
Fellowship participants will have complete access to ISSCA’s accredited stem cell advanced lab protocols. The ISSCA Fellowship program is a 6-day program that offers a certificate of completion issued by ISSCA and Westminster International University in Seoul. Students who complete the fellowship become members of the ISSCA’s international network of regenerative medical professionals and standard setters, with access to events, resources, training, and support moving forward.
ISSCA is the only organization that provides a complete cell therapy and tissue engineering fellowship focused on regenerative medicine. It is also the only fellowship of its kind supported by Korean Universities.
To learn more about the ISSCA fellowship and to reserve a spot at the October 2018 program in Korea, visit the Fellowship in Cell Therapy and Tissue Engineering website, email info@stemcellsgroup.com, or call +1 813 510 9403
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
cell therapy fellowship
- Published in Press Releases
ISSCA to sponsor First Congress of Aesthetic Medicine Oct. 17 – 19, 2018 in Santa Cruz, Bolivia
ISSCA will sponsor the first Congress of Aesthetic Medicine in Santa Cruz, Bolivia Oct. 17, 18, and 19, 2018.
MIAMI, July 17, 2018—The International Society for Stem Cell Application (ISSCA) has announced plans to sponsor the First Congress of Aesthetic Medicine in Santa Cruz, Bolivia, October 17, 18, and 19, 2018. More than 300 Bolivian physicians are expected to attend the event.
The 3-day conference will offer plenty of regenerative medicine product information and educational activities for aesthetic practitioners, including:
* GSCG Research Director, faculty member, and stem cell authority Maritza Novas, a certified ISSCA specialist for more than four years, will conduct a seminar on stem cell applications in cosmetic, anti-aging, and tissue regeneration procedures—and the benefits they offer patients receiving aesthetic treatments. * ISSCA will conduct its intensive, hands-on stem cell certification training course for physicians attending the conference. Highly qualified trainers instruct physicians in harvesting, isolating, and reintegrating bone marrow- and adipose-derived stem cells using live patients. Upon completing the two-day training course, physicians will be ready to begin practicing regenerative medicine procedures in their medical office without the need to utilize an external lab to obtain stem cells. Course curriculum consists of comprehensive theoretical lectures and home study education, and two days of didactic and clinical experience. One day of post-educational on-site clinical assistance is also available upon request.
* ISSCA affiliate Global Stem Cells Group (GSCG) and Adimarket, GSCG’s online store for regenerative medicine practitioners, will launch two new aesthetic regenerative medicine products under the company’s Cellgenic label, featuring adipose-derived stem cell (ADSC) proteins extract (AAPE). Containing a mixture of refined growth factor proteins extracted from human stem cells, AAPE’s conditioned media offers the benefits of a unique protein formula that maximizes the revitalizing capabilities in skin and hair follicles. The benefits of AAPE include:
•Active proteins derived from human sources, no risk of allergic reaction/skin irritation • Natural composition of ADSC-derived growth factors provide superior biological activity • Multi-functional • CADPE exhibits anti-oxidation, skin-whitening and hair re-growth • Synergistic effect • Each growth factor has a pharmacological effect but the combination of growth factors may enhance the pharmacological action of single proteins.
The event will be held at the Hotel Los Tabijos in Santa Cruz. To learn more about ISSCA, visit the ISSCA website. For registration information, email info@stemcellsgroup.com or call 305-560-5337.
About ISSA:|\
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world. About Adimarket: Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
About Adimarfket:
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting.
Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
Aesthetic medicine conference
- Published in Press Releases
ISSCA introduces new stem cell training courses web page for regenerative medicine practitioners
ISSCA has launched a new stem cell training web page designed to offer free information and resources to help physicians choose a training program best suited to their unique needs.
MIAMI, June 26, 2018—The International Society for Stem Cell Application (ISSCA) has launched a new stem cell training course web page, coordinated by Global Stem Cells Group affiliate Stem Cell Training, designed to help physicians access free information and resources on the newest instruction and training options in regenerative medicine training.
The new web page is designed to help physicians interested in adding stem cell procedures to grow their medical practice or enhance career advancement opportunities find stem cell training program options to enable them to find a training program best suited to their individual needs. ISSCA’s variety of stem cell training opportunities include:
• Online stem cell training course, ISSCA’s cutting-edge online course that teaches physicians everything they need to know to add adult stem cell-based procedures to their existing practice, or confidently transition to a regenerative medicine center. Offering the convenience of training from a home or office computer, this course prepares physicians in all the theoretical and practical knowledge needed to effectively and expertly administer stem cell therapies to patients, including harvesting and isolating stem cells.
ISSCA’s online training positions physicians to open their own stem cell center practice and join ISSCA’s expansive network. Successful completion of the online training course allows physicians to immediately begin offering cutting-edge regenerative medicine procedures to patients, establish themselves as experts in their fields, and enjoy the benefits of the growing regenerative medicine industry.
• Hands-on stem cell certification training courses, ISCCA’s intensive, two-day hands-on training course scheduled at various international locations provides attending physicians with expert instruction on autologous stem cell therapies in the field of regenerative medicine. Participants learn techniques and protocols for harvesting and isolating stem and regenerative cells from adipose tissue, bone marrow, and /or peripheral blood from live patients and administering the cells back to the patient
Course curriculum consists of comprehensive theoretical lectures and home study education, and two days of didactic and clinical experience. One day of post-educational on-site clinical assistance is also available upon request.
• Onsite training, ISSCA’s personalized, hands-on, onsite stem cell training brings stem cell specialists to your practice or clinic, anywhere in the world, to provide one-on-one training tailored to your practice’s specific requirements—saving time and money. The onsite training program offers participants a unique opportunity to grow their practice and achieve their specific practice goals by offering practice-specific regenerative medicine treatments to patients in their medical office or clinical setting.
The onsite training course provides participating practices with personalized theoretical information and hands-on training along with ongoing support for their clinical practice. Applications and protocols are provided by a Stem Cells Training faculty member with extensive experience in laboratory and clinical practice.
ISSCA’s onsite training specifications include:
1. Equipment and supply delivery. The Stem Cell Training team
delivers and sets up all equipment and supplies necessary for the training session to take place and will leave the physician’s team
fully qualified to start its own stem cell treatment practice.
2. Expert trainers. ISSCA’s onsite stem cell training course takes a highly visual and interactive approach. Expert trainers teach and supervise the hands-on process using live patients and different protocols for the extraction, isolation, and application of PRP, adipose- and bone marrow-derived stem cells.
3. Multimedia access. ISSCA provides physicians participating in its onsite training program access to its library of high-resolution, step-by-step procedure videos and ongoing online and telephone support for clinical equipment, inquiries or concerns for the practice’s future use and reference.
• Fellowship in cell therapy and tissue engineering. Recognizing the need for knowledge of stem cell protocols among physicians and healthcare professionals, ISSCA and Stem Cell Training created the Fellowship of Stem Cell Therapy and Tissue Engineering program. The fellowship focuses on stem cell therapies involving the potential replacement of cells or organs that are diseased, injured, infirmed, ailing or aged
In this modular training program, a group of experienced academic scholars involved in stem cell transplantation present a series of topics covering the general principles and practices of stem cell
biology and evidence-based treatments that physicians can apply to optimize the health of their patients. Fellowship course details and objectives include:
• A detailed program offering hands-on experience in stem cell characterization and laboratory applications
• An opportunity to learn cell culture processes including plating, trypsinization, harvesting, and cryopreservation
• Gaining the ability to understand and apply quality control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma, and sterility
• Learning to perform CGMP functions including clean room maintenance, gowning, and environmental monitoring
• Establishing insight on relevant applications of stem cell processing and regulations that apply to a certified facility
• Receiving the tools necessary to implement regulatory and clinical guidelines when setting up a GMP facility
• Providing participants with copies of presentations, procedural protocols, and all forms associated with a GMP facility, as well as case books and full protocols for approximately 30 indications
• Demonstrating the ability to perform clinical procedures including lipoaspirate and bone marrow isolation, and reintroduction of stem cells for various indications
The new ISSCA stem cell training web page also features an informative blog that publishes four new articles in the field of regenerative medicine weekly.
To learn more, visit the ISSCA stem cell training web page, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Stem cell training web page launch
- Published in Press Releases
Adimarket announces launch of Cellgenic stem cell protein extract hair restoration product
GSCG affiliate Adimarket announces the launch of the Cellgenic adipose-derived stem cell hair restoration application that maximizes the skin and hair follicles’ own revitalizing capabilities.
MIAMI, June 26, 2018—Global Stem Cells Group (GSCG) affiliate Adimarket announces the launch of the Cellgenic adipose-derived stem cells protein extract (CADPE) hair restoration application product.
CADPE combines refined growth factor proteins extracted from human adipose-derived stem cells in a conditioned media and a unique protein formula, to maximize the revitalizing characteristic of skin and hair follicles.
CADPE increases the reproduction of human follicles’ dermal papilla cells, which consist of a distinct population of specialized fibroblasts important in morphogenesis (differentiation and growth) of the hair follicle structure and control of the hair growth cycle, CADPE works by turning over dying skin cells at twice the frequency of normal skin,
CADPE benefits:
• Use of active proteins derived from human sources eliminates concerns with allergic reactions and skin irritation
• The natural composition of the product’s various growth factors acquired from adipose-derived stem cells can provide exceptional biological activity
• CADPE is multi-functioning, exhibiting anti-oxidation and hair re-growth effects
• Each growth factor has a pharmacological effect, but the combination of growth factors has a synergistic effect that can enhance the pharmacological action of single proteins.
• No special training is needed to learn how to use CADPE
• The CADPE application procedure is shorter than other hair restoration protocols, which can take up to eight hours per patient
• CADPE is supported by scientific evidence
When used by aesthetic practitioners, CADPE provides safe, cutting-edge hair thickening and hair follicle proliferation results that are CTFA-approved, take less application time than other hair restoration processes, and is backed by medical research.
Cellgenic adipose-derived stem cells protein extract can be purchased online at the Adimarket online store. For more information, visit the Adimarket website, email info@stemcellsgroup.com, or call 305-560-5337.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
CADPE stem cell hair restoration application
- Published in Press Releases
Which Works Better, Viscosupplementation, or Platelet Rich Plasma?
Introduction to Viscosupplementation
One of the treatments approved by the FDA for knee arthritis is Hyaluronic Acid (HA) injection, commonly known as viscosupplementation. This treatment has shown significant success in managing knee arthritis and is increasingly being explored for other parts of the body, such as the hip and shoulder, although these uses are not FDA-approved. HA injections mimic the fluid that naturally surrounds your joints, acting as a lubricant and shock absorber, thereby reducing arthritis pain. Over time, HA is absorbed into the joint, potentially stimulating the body to produce more stable cartilage.
Evidence Supporting Viscosupplementation
The evidence supporting HA injections is robust. A systematic review of 76 randomized controlled trials concluded that HA injections can improve function, reduce pain, and serve as a reliable treatment for knee osteoarthritis.
The Role of Platelet-Rich Plasma (PRP) in Treating Arthritis
What is Platelet-Rich Plasma (PRP)?
Platelet-Rich Plasma (PRP) is a concentrate of platelets in plasma, containing 6 to 10 times more platelets than normal blood. PRP is rich in growth factors, such as Epidermal Growth Factor (EGF) and Connective Tissue Growth Factor (CTGF), which promote healing by leveraging the body’s natural healing mechanisms.
FDA Regulation and Research on PRP
Unlike HA, PRP is not FDA-regulated, and the devices used to prepare PRP are subject to FDA approval. Despite this, numerous studies have demonstrated PRP’s efficacy in treating tendon injuries and osteoarthritis, as well as in reducing pain. Ongoing research is exploring its potential benefits for hair regrowth, cardiac muscle repair, and dermatologic rejuvenation.
Comparing HA Injections and PRP
Effectiveness and Safety
Studies indicate that PRP can be just as effective, if not more so, than HA injections. While HA is FDA-approved only for knee use, PRP is derived from the patient’s own blood, reducing the risk of infection and autoimmune reactions, thanks to the presence of white blood cells that help fight infections.
Cost Considerations
HA injections for joints other than the knee are not FDA-approved or typically covered by insurance, often costing patients $1500 or more, excluding additional charges like doctor visits and the injection itself. In contrast, PRP treatments generally cost between $800 and $1200 out of pocket.
Conclusion: Which is the Better Choice?
PRP has demonstrated comparable or superior effectiveness to HA injections for arthritis pain management. It carries a lower risk of infection or autoimmune reactions and is generally more cost-effective. Given these advantages, PRP often emerges as the preferred choice for many patients and healthcare providers.
- Published in Corporate News / Blog
Global Stem Cells Group to sponsor the American Association of Stem Cell Physicians summit in Miami
Global Stem Cells Group will sponsor the American Association of Stem Cell Physicians summit in Miami August 10 – 12, 2018.
MIAMI, June 18, 2018—Global Stem Cells Group (GSCG), a world leader in regenerative medicine, announces its sponsorship of the American Association of Stem Cell Physicians (AAOSCP) summit in Miami, August 10-12, 2018. The conference will offer three days of educational, workshop, and networking events with physicians and researchers from around the world in the fields of stem cell and regenerative medicine. Attending physicians can earn up to 24 CME credits.
Summit attendees will have the opportunity to learn about Adimarket, GSCG’S fast-growing online store for regenerative medicine practitioners to conveniently purchase products, supplies, and equipment that meets their specific clinical needs.
GSCG affiliate Stem Cell Training, Inc. (SCT) will also be on hand to provide qualified Summit attendees with personalized, hands-on regenerative medicine training course at the summit, which will be conducted by expert instructors who guide qualified physicians through the intensive, two-day certification program. Benefits of this stem cell training course include:
- Stem Cell Training’s state-of-the-art, one-on-one regenerative medicine training on the latest stem cell procedures and protocols to use immediately in private clinical practice
- Access to SCT’s online resources, personalized theoretical information, and hands-on training with live patients, as well as ongoing support for each participating physician’s clinical practice
- Stem cell applications and protocols demonstrated by an SCT faculty member with extensive experience in laboratory and clinical practices
Physicians and businesses professionals in the field of regenerative medicine, the AAOSCP summit offers an outstanding opportunity to connect with others in the industry, explore, learn, and make connections while learning about the latest groundbreaking treatments and technologies. Medical students and those seeking careers on the business side of the regenerative medicine market can take advantage of the valuable opportunity the summit offers to network with potential employers while learning about groundbreaking treatments and therapies.
Since 2014, Global Stem Cells Group has worked with some of the most prestigious regenerative medicine practitioners in the U.S., South America, and Asia as it focuses on growing its services throughout the global community. Stem cell therapies continue to revolutionize the healthcare industry while offering new hope for sufferers of chronic, debilitating conditions.
For more information and to register for the summit, visit the AAOSCP website, email info@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations. Each corporation is focused on furthering scientific and technological advancements in cutting-edge stem cell research, development, treatment, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop epicenter for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
American Association of Stem Cell Physicians summit
- Published in Press Releases
ISSCA to sponsor XX International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity in Mexico City
ISSCA will sponsor the XX International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity in Mexico City July 13, 14 and 15, 2018. This will mark the international stem cell organization’s third consecutive year sponsoring the event.
MIAMI, June 18, 2018—The International Society for Stem Cell Application (ISSCA), will sponsor the XX International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity in Mexico City July 13, 14 and 15, 2018. The event marks ISSCA’s third consecutive year of sponsorship for the event, expected to attract aesthetic and regenerative medicine physicians from around the world.
ISSCA affiliate Global Stem Cells Group (GSCG) will launch its newest regenerative medicine products for the aesthetic market and present master classes for Congress attendees in clinical stem cell applications digital marketing for aesthetic practices:
• Clinical Stem Cell Applications master class conducted by GSCG Research Director Maritza Novas, stem cell application and anti-aging specialist.
• Social Media marketing master class Digital Marketing: A New Challenge to the Aesthetic Market, conducted by Benito Novas, Global Stem Cells Group CEO, and medical marketing specialist.
Global Stem Cells Group will also launch its Cellgenic Hair adipose-derived stem cell (ADSC) proteins extract (AAPE). Containing a mixture of refined growth factor proteins extracted from human stem cells, AAPE’s conditioned media offers a unique protein formula that maximizes the revitalizing capabilities in skin and hair follicles.
Key factors of AAPE include:
- Human proteins
- Active proteins are derived from human sources with no risk of allergic reactions or skin irritation
- The natural composition of assorted growth factors derived from ADSCs can provide the best biological activity
- Synergistic effect: each growth factor has a unique pharmacological effect, and the combination AAPE’s of growth factors may enhance the pharmacological action of a single protein.
- Multi-function: AAPE demonstrates anti-oxidation, skin whitening, and hair regrowth capabilities.
The conference will be held at the Hotel Fiesta Americana Reforma in Mexico City.
To learn more about registering to attend, please visit the XX International Congress of Aesthetic Medicine, Aesthetic Surgery, and Obesity website, email mailto:info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
XX International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity
- Published in Press Releases
